Detalhe da pesquisa
1.
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
N Engl J Med
; 389(16): 1453-1465, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851874
2.
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study Results.
Oncologist
; 28(5): e309-e312, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994854
3.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
N Engl J Med
; 382(23): 2187-2196, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469183
4.
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.
Oncologist
; 27(6): 453-461, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373299
5.
Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome.
World J Urol
; 40(4): 983-989, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084544
6.
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated Antigens.
Mol Ther
; 28(5): 1238-1250, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208168
7.
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.
World J Urol
; 38(12): 3101-3111, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32088746
8.
Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection.
Can J Urol
; 27(3): 10213-10219, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32544043
9.
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer.
Cancer
; 125(23): 4172-4180, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483485
10.
Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.
World J Urol
; 36(5): 801-809, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380128
11.
24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
BJU Int
; 118 Suppl 3: 14-22, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27684483
12.
Reply Letter By Author.
Can J Urol
; 28(1): 10508-10509, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625339
13.
Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data.
Cancer
; 126(12): 2935-2937, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154908
14.
Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
BJU Int
; 113(4): 615-22, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24765680
15.
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
JAMA Oncol
; 10(5): 594-602, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451492
16.
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study.
Eur Urol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38644146
17.
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
Adv Ther
; 40(11): 4919-4927, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713020
18.
Transurethral Vapor Ablation in Patients with Intermediate-Risk Localized Prostate Cancer.
J Endourol
; 37(2): 225-232, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310434
19.
A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.
Target Oncol
; 18(3): 383-390, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060432
20.
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
Cancers (Basel)
; 15(19)2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835548